Blog
3 Signs You're On Track to Retire a Millionaire
Approximately 233,000 Americans have at least $1 million stashed in their 401(k) accounts, according to a report from Fidelity Investments.
If your goal is to join that exclusive club, you'll need
2 Stocks to Buy Before a Coronavirus Vaccine Arrives
When will we get a COVID-19 vaccine? This seems to be the billion-dollar question behind the ups and downs of all the reopening stocks -- that is, the companies that stand to benefit as life in the
Betting Against IDEXX Labs Because of Coronavirus? You May Be Barking Up the Wrong Tree
Estimates vary, but humans have likely had pets since dogs joined us in our first permanent settlements 25,000 years ago. Today, more than half of humans globally have at least one pet living with
Taking a CARES Act Retirement Plan Withdrawal? Prepare for This Tax Surprise
Millions of Americans have lost their jobs in the course of the COVID-19 outbreak, and even those who are working may be grappling with financial concerns. If you're finding yourself needing money
3 Dividend Stocks Perfect for Retirees
What's the recipe for the perfect stock for retirees? Mix a hefty amount of stability with a generous heap of dividends. Then add at least a pinch of growth. Let the concoction simmer, and you
2 Great Pharma Stocks to Buy in the Next Market Crash
AbbVie (NYSE: ABBV) and Gilead Sciences (NASDAQ: GILD) are stable giants in the pharmaceutical industry. Both companies have an extensive array of products on the market, not to mention plenty of
For Investors in Danaher Stock, Breaking Up Should Be Hard to Do
Frasier, Better Call Saul, Joanie Loves Chachi: TV spinoffs can be beloved connections to the past or outright duds. Corporate spinoffs, luckily, are more predictable; they have long been a source
Better Marijuana Stock: Green Thumb Industries vs. GrowGeneration
If you want proof that the U.S. cannabis market is booming, just look at Green Thumb Industries (OTC: GTBIF) and GrowGeneration (NASDAQ: GRWG). Both companies reported sizzling sales growth in their
3 Coronavirus Vaccines in Phase 3 Clinical Studies: How They Stack Up Against Each Other
Any way you look at it, the numbers related to coronavirus vaccine candidates in development are impressive. In less than nine months, researchers have advanced 180 experimental coronavirus vaccines
Trump's 3 Most Ridiculous Social Security Ideas
For more than 80 years, Social Security has been providing a financial foundation for our nation's retired workers who can no longer provide for themselves. It's arguably our country's most
3 Cheap Stocks You Can Buy and Hold for Decades
Even with the recent pullback, the stock market remains near all-time highs. There aren't many stocks with attractive valuations. Of those, quite a few aren't the kinds of stocks you'd want to touch
Citigroup Has to Answer an Important Question for Investors -- and Regulators
Everyone makes mistakes, including big corporations. Unfortunately, when the largest global banks make them, those mistakes tend to have a lot of zeroes after them and create all sorts of
Got $300? 4 Great Stocks to Buy in a Volatile Market
Investing in 2020 has been challenging, to say the least. In a roughly six-month stretch, the stock market plunged at a faster pace than ever before, as well as rebounded to new highs more quickly
The Top 2 IPO Stocks to Avoid This September
Two of the hottest IPO stocks investors are talking about in September are coronavirus vaccine developer CureVac (NASDAQ: CVAC) and cloud-data giant Snowflake (NYSE: SNOW). In a short amount of
5-Stock Recommendations Review, Five Years Later
In this episode of Rule Breaker Investing: Review-a-palooza! The Motley Fool co-founder David Gardner is joined by The Motley Fool's Maria Gallagher to review 10 stock recommendations from past
Abbott Launches World's First Glucose Monitor for Athletes
Glucose biosensors are typically used by people with diabetes to track their blood sugar levels while avoiding traditional finger-stick tests that accomplish the same goal.
Abbott Laboratories
Curaleaf Hires a New Retail Chief
Curaleaf Holdings (OTC: CURLF) has replaced one of its key executives. The company announced Thursday that it has named Talley Wettlaufer to the position of senior vice president of retail --
Beyond Coronavirus: Moderna Teams Up With Vertex on Cystic Fibrosis Therapy
All eyes are on Moderna's (NASDAQ: MRNA) coronavirus vaccine, but the biotech is looking ahead, setting up a new research collaboration with Vertex Pharmaceuticals (NASDAQ: VRTX) to develop a
Why Snowflake Stock Fell Today
Shares of Snowflake (NYSE: SNOW) declined by 10.4% on Thursday, giving back some of the cloud-based data management company's first-day gains.
To say Snowflake had a blockbuster initial public
Why Moderna Was So Volatile on Thursday
Moderna (NASDAQ: MRNA) was a roller-coaster stock on Thursday, at one point trading 3% higher, then as much as 6% lower, before settling in for a 1.3% loss at the end of the day.
A business update
Walmart Responds to Changing Retail Structure, Increased Pickup and Delivery With Pay Hikes
Walmart (NYSE: WMT) announced in a press release today it's boosting the pay of approximately 165,000 of its associates. It has slated increases not only to hourly minimums but to the possible pay
Report: Walmart India Unit Flipkart to Launch IPO
Flipkart, the prominent e-tailer based in India that is owned by Walmart (NYSE: WMT), is preparing for an initial public offering (IPO). That's according to an article published Wednesday by
Why Kodak Stock Soared Today
Shares of Eastman Kodak (NYSE: KODK) surged 25.6% on Thursday, furthering the stock's rebound following its internal investigation of the events surrounding its loan award from the U.S. government.
CME Group Launching "First-of-its-Kind" Water Futures Product
Investors can buy and sell futures contracts for items like pork bellies and oil, so why not for water too? Securities exchange operator CME Group (NASDAQ: CME), which specializes in financial
New York Files Charges Against Johnson & Johnson Over Opioid Marketing
New York's Department of Financial Services filed civil charges against Johnson & Johnson (NYSE: JNJ) on Thursday, accusing the biopharmaceutical giant of downplaying the risks to patients


